Connect with us

Technology

Vapotherm Reports Second Quarter 2024 Financial Results

Published

on

EXETER, N.H., Aug. 12, 2024 /PRNewswire/ — Vapotherm, Inc. (OTCQX: VAPO), (“Vapotherm” or the “Company”), today announced second quarter 2024 financial results and related highlights.

Second Quarter 2024 Financial Results and Related Highlights

Net revenue for the second quarter of 2024 was $16.9 million, an increase of 5.3% as compared to the second quarter of 2023Disposables revenue increased by 13.9% as compared to the second quarter of 2023U.S. disposables revenue increased by 25.9% as compared to the second quarter of 2023Gross margin in the second quarter of 2024 was 49.1% as compared to 42.8% in the second quarter of 2023For the second quarter of 2024, GAAP operating expenses were $17.6 million and non-GAAP cash operating expenses, as defined below, were $12.1 millionGAAP operating expenses increased by $0.5 million from the second quarter of 2023Non-GAAP cash operating expenses decreased by $2.1 million from the second quarter of 2023Adjusted EBITDA loss in the second quarter of 2024 was $2.9 million as compared to an Adjusted EBITDA loss of $6.4 million in the second quarter of 2023The Company’s unrestricted cash and cash equivalents were $2.9 million at the end of the second quarter of 2024

“I’m pleased our U.S. disposables revenue grew by nearly 26% over the second quarter of 2023 and our worldwide disposables revenue grew by nearly 14% over the same period,” said Joseph Army, President and CEO. “We are seeing increased adoption of our technology on COPD patients since the results of the HYPERACT study were presented at the 2024 Critical Care Congress.”

Results for the Three Months Ended June 30, 2024

The following table reflects the Company’s net revenue for the three months ended June 30, 2024 and 2023:

Three Months Ended June 30,

2024

2023

Change

(in thousands, except percentages)

Amount

% of Revenue

Amount

% of Revenue

$

%

Revenue

Capital (product & lease revenue)

$

3,061

18.1

%

$

3,646

22.7

%

$

(585)

(16.0)

%

Disposables

12,442

73.7

%

10,927

68.1

%

1,515

13.9

%

Service and other

1,381

8.2

%

1,464

9.2

%

(83)

(5.7)

%

Total net revenue

$

16,884

100.0

%

$

16,037

100.0

%

$

847

5.3

%

Net revenue for the second quarter of 2024 was $16.9 million and increased 5.3% over the second quarter of 2023 primarily due to U.S. disposables revenue growth of 25.9% over the second quarter of 2023, which was driven by increased unit volume and adoption of the Company’s HVT 2.0 platform.

Revenue information by geography is summarized as follows:

Three Months Ended June 30,

2024

2023

Change

(in thousands, except percentages)

Amount

% of Revenue

Amount

% of Revenue

$

%

United States

$

13,323

78.9

%

$

11,847

73.9

%

$

1,476

12.5

%

International

3,561

21.1

%

4,190

26.1

%

(629)

(15.0)

%

Total net revenue

$

16,884

100.0

%

$

16,037

100.0

%

$

847

5.3

%

Net revenue in the United States for the second quarter of 2024 was $13.3 million and increased 12.5% over the second quarter of 2023 primarily due to U.S. disposables revenue growth. Net revenue in International markets for the second quarter of 2024 was $3.6 million and decreased 15.0% over the second quarter of 2023 due to a decrease in disposables revenue in distributor markets.

Gross profit and gross margin for the second quarter of 2024 was $8.3 million and 49.1%, respectively, as compared to gross profit of $6.9 million and gross margin of 42.8% for the second quarter of 2023. The increases in gross profit and gross margin were primarily due to the improved efficiency of our Mexico operation.

Total operating expenses were $17.6 million in the second quarter of 2024, an increase of $0.5 million as compared to the second quarter of 2023. Non-GAAP cash operating expenses, which exclude merger-related costs, gain on disposal of property and equipment, depreciation and amortization, stock-based compensation expense, and gain from deconsolidation were $12.1 million in the second quarter of 2024 compared to $14.2 million in the second quarter of 2023. The increase in operating expenses was primarily due to merger-related costs, partially offset by the Company’s Path to Profitability initiatives. The decrease in non-GAAP cash operating expenses was primarily due to the Company’s Path to Profitability initiatives.

Net loss for the second quarter of 2024 was $14.3 million, or $2.22 per share, compared to $14.8 million, or $2.34 per share, in the second quarter of 2023. Net loss per share was based on 6,442,763 and 6,328,222 weighted average shares outstanding for the second quarter of 2024 and 2023, respectively.

Adjusted EBITDA was negative $2.9 million for the second quarter of 2024 as compared to negative $6.4 million for the second quarter of 2023. The reduction in Adjusted EBITDA loss was primarily due to the Company’s Path to Profitability initiatives.

Cash Position

Unrestricted cash and cash equivalents were $2.9 million as of June 30, 2024 compared to $9.7 million as of December 31, 2023.

Website Information

Vapotherm routinely posts important information for investors on the Investor Relations section of its website, http:// investors.vapotherm.com/. Vapotherm intends to use this website as a means of disclosing material, non-public information and for complying with Vapotherm’s disclosure obligations under Regulation FD. Accordingly, investors should monitor the Investor Relations section of Vapotherm’s website, in addition to following Vapotherm’s press releases, Securities and Exchange Commission (“SEC”) filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, Vapotherm’s website is not incorporated by reference into, and is not a part of, this document.

Non-GAAP Financial Measures

This press release includes non-GAAP financial measures, including EBITDA, Adjusted EBITDA, non-GAAP operating expenses and non-GAAP cash operating expenses. EBITDA and Adjusted EBITDA differ from net income as calculated in accordance with U.S. generally accepted accounting principles (“GAAP”) and non-GAAP operating expenses and non-GAAP cash operating expenses differ from operating expenses as calculated in accordance with GAAP. EBITDA represents net loss less interest expense, net, income tax provision or benefit, and depreciation and amortization, and Adjusted EBITDA represents EBITDA as further adjusted for the merger-related costs, impact of foreign currency (loss) gain, stock-based compensation expense, gain from deconsolidation and gain on disposal of property and equipment. Non-GAAP operating expenses is calculated by excluding from GAAP operating expenses merger-related costs, gain on disposal of property and equipment, and non-GAAP cash operating expenses is calculated by further excluding additional items, including stock-based compensation expense, depreciation and amortization, and gain from deconsolidation. The Company has reconciled all historical non-GAAP financial measures with the most directly comparable GAAP financial measures in tables accompanying this release.

These non-GAAP financial measures are presented because the Company believes they are useful indicators of its operating performance. Management uses these non-GAAP financial measures, as measures of the Company’s operating performance and for planning purposes, including the preparation of the Company’s annual operating budget and financial projections. The Company believes these measures are useful to investors as supplemental information because they are frequently used by analysts, investors and other interested parties to evaluate companies in its industry. The Company believes Adjusted EBITDA is useful to its management and investors as a measure of comparative operating performance from period to period.

These non-GAAP financial measures should not be considered alternatives to, or superior to, net income or loss as a measure of financial performance or cash flows from operations as a measure of liquidity, or any other performance measure derived in accordance with GAAP. They should not be construed to imply that the Company’s future results will be unaffected by unusual or non-recurring items. In addition, Adjusted EBITDA is not intended to be a measure of free cash flow for management’s discretionary use, as it does not reflect certain cash requirements such as tax payments, debt service requirements, capital expenditures and certain other cash costs that may recur in the future. Adjusted EBITDA contains certain other limitations, including the failure to reflect our capital expenditures, cash requirements for working capital needs and cash costs to replace assets being depreciated and amortized. In evaluating Adjusted EBITDA, you should be aware that in the future the Company may incur expenses that are the same as or similar to some of the adjustments in the Adjusted EBITDA presentation. The Company’s presentation of Adjusted EBITDA should not be construed to imply that its future results will be unaffected by any such adjustments. Management compensates for these limitations by primarily relying on the Company’s GAAP results in addition to using Adjusted EBITDA and other non-GAAP financial measures on a supplemental basis. The Company’s definitions of Adjusted EBITDA, non-GAAP operating expenses and non-GAAP cash operating expenses are not necessarily comparable to other similarly titled captions of other companies due to different methods of calculation.

About Vapotherm

Vapotherm, Inc. (OTCQX: VAPO) is a publicly traded developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, USA. The Company develops innovative, comfortable, non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. Over 4.5 million patients have been treated with the use of Vapotherm high velocity therapy® systems. For more information, visit www.vapotherm.com.

Vapotherm high velocity therapy is mask-free non-invasive respiratory support and is a front-line tool for relieving respiratory distress—including hypercapnia, hypoxemia, and dyspnea. It allows for the fast, safe treatment of undifferentiated respiratory distress with one tool. The HVT 2.0 and Precision Flow systems’ mask-free interface delivers optimally conditioned breathing gases, making it comfortable for patients and reducing the risks and care complexities associated with mask therapies. While being treated, patients can talk, eat, drink and take oral medication.

Legal Notice Regarding Forward-Looking Statements

This press release contains forward-looking statements under the Private Securities Litigation Reform Act of 1995, including the statement about the Company’s belief regarding an increased willingness to use the Company’s technology on COPD patients. In some cases, you can identify forward-looking statements by terms such as “believe,” “expect,” “continue,” “plan,” “intend,” “will,” “outlook,” or “typically,” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words, and the use of future dates. Each forward-looking statement is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statement. Applicable risks and uncertainties include, but are not limited to the following: Vapotherm’s proposed merger with Veronica Merger Sub, Inc. and Vapotherm’s ability to satisfy the conditions to closing or otherwise complete the merger on a timely basis or at all and the impact the pending merger may have on Vapotherm’s current plans and operations, including potentially diverting management’s attention from our business; the effects of the merger (or the announcement or pendency thereof) on Vapotherm’s future business and financial and operating results, its ability to retain key personnel and maintain relationships with customers, manufacturers, suppliers, employees (including the risks relating to the ability to retain or hire key personnel), other business partners or governmental entities, and the risk and outcome of legal proceedings related to the merger; Vapotherm’s ability to raise additional capital to fund its existing operations and debt service obligations; Vapotherm’s ability to comply with its financial covenants, execute on its path to profitability initiative, convert excess inventory into cash and fund its business and otherwise continue as a going concern through 2024; Vapotherm has incurred losses in the past and may be unable to achieve or sustain profitability in the future; risks associated with its manufacturing operations in Mexico; Vapotherm’s dependence on sales generated from its High Velocity Therapy systems, competition from multi-national corporations who have significantly greater resources than Vapotherm and are more established in the respiratory market; the ability for High Velocity Therapy systems to gain increased market acceptance; Vapotherm’s inexperience directly marketing and selling its products; the potential loss of one or more suppliers and dependence on its new third party manufacturer; Vapotherm’s susceptibility to seasonal fluctuations; Vapotherm’s failure to comply with applicable United States and foreign regulatory requirements; the failure to obtain U.S. Food and Drug Administration or other regulatory authorization to market and sell future products or its inability to secure, maintain or enforce patent or other intellectual property protection for its products; the impact of COVID on its business, including its supply chain; risks in holding Vapotherm stock in light of trading on the OTCQX tier of the OTC Markets; and the other risks and uncertainties included under the heading “Risk Factors” in Vapotherm’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as filed with the SEC on February 22, 2024, and subsequent SEC reports. The forward-looking statements contained in this press release reflect Vapotherm’s views as of the date hereof, and Vapotherm does not assume and specifically disclaims any obligation to update any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law.

 

VAPOTHERM, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share amounts)

June 30, 2024

December 31, 2023

(unaudited)

Assets

Current assets

Cash and cash equivalents

$

2,904

$

9,725

Accounts receivable, net of expected credit losses
   of $240 and $160, respectively

8,563

10,672

Inventories, net

23,295

22,968

Prepaid expenses and other current assets

2,259

3,058

Total current assets

37,021

46,423

Property and equipment, net

23,592

23,703

Operating lease right-of-use assets

2,911

3,372

Restricted cash

1,109

1,109

Goodwill

561

565

Deferred income tax assets

56

57

Other long-term assets

2,677

2,388

Total assets

$

67,927

$

77,617

Liabilities and Stockholders’ Deficit

Current liabilities

Accounts payable

$

4,381

$

5,053

Contract liabilities

1,258

1,237

Accrued expenses and other current liabilities

22,913

12,805

Current portion of loans payable, net

118,406

–

Total current liabilities

146,958

19,095

Long-term loans payable, net

–

107,059

Other long-term liabilities

2,288

6,797

Total liabilities

149,246

132,951

Commitments and contingencies

Stockholders’ deficit

Preferred stock ($0.001 par value) 25,000,000 shares authorized; no shares
   issued and outstanding as of June 30, 2024 and December 31, 2023

–

–

Common stock ($0.001 par value) 21,875,000 shares authorized as of
   June 30, 2024 and December 31, 2023, 6,241,958 and 6,165,806
   shares issued and outstanding as of June 30, 2024 and
   December 31, 2023, respectively

6

6

Additional paid-in capital

496,083

492,764

Accumulated other comprehensive (loss) income

(106)

91

Accumulated deficit

(577,302)

(548,195)

Total stockholders’ deficit

(81,319)

(55,334)

Total liabilities and stockholders’ deficit

$

67,927

$

77,617

 

VAPOTHERM, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share and per share amounts)

Three Months Ended June 30,

Six Months Ended June 30,

2024

2023

2024

2023

(unaudited)

(unaudited)

Net revenue

$

16,884

$

16,037

$

36,018

$

33,768

Cost of revenue

8,601

9,177

18,078

20,696

Gross profit

8,283

6,860

17,940

13,072

Operating expenses

Research and development

3,328

3,723

6,960

7,710

Sales and marketing

6,732

8,276

13,874

17,868

General and administrative

3,768

5,019

8,240

10,789

Merger-related costs

3,723

–

3,723

–

Impairment of right-of-use assets

–

–

–

432

(Gain) loss on disposal of property and equipment

(1)

(2)

(9)

53

Total operating expenses

17,550

17,016

32,788

36,852

Loss from operations

(9,267)

(10,156)

(14,848)

(23,780)

Other (expense) income

Interest expense

(4,944)

(4,642)

(14,197)

(8,973)

Interest income

1

26

6

54

Foreign currency (loss) gain

(43)

9

(39)

(145)

Net loss before income taxes

$

(14,253)

$

(14,763)

$

(29,078)

$

(32,844)

Provision for income taxes

18

25

29

34

Net loss

$

(14,271)

$

(14,788)

$

(29,107)

$

(32,878)

Other comprehensive (loss) income:

Foreign currency translation adjustments

(35)

(22)

(197)

113

Total other comprehensive (loss) income

(35)

(22)

(197)

113

Total comprehensive loss

$

(14,306)

$

(14,810)

$

(29,304)

$

(32,765)

Net loss per share – basic and diluted

$

(2.22)

$

(2.34)

$

(4.52)

$

(5.76)

Weighted-average number of shares used in calculating net
   loss per share, basic and diluted (1)

6,442,763

6,328,222

6,436,631

5,705,607

(1) On August 18, 2023, the Company effected a 1:8 reverse stock split for each share of common stock issued
and outstanding. All shares and associated amounts have been retroactively restated to reflect the stock split.

 

VAPOTHERM, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)

Six Months Ended June 30,

2024

2023

Cash flows from operating activities

Net loss

$

(29,107)

$

(32,878)

Adjustments to reconcile net loss to net cash used in operating activities

Stock-based compensation expense

3,290

5,405

Depreciation and amortization

2,528

2,445

Provision for credit losses

110

(2)

Provision for inventory valuation

73

283

Non-cash lease expense

461

733

Impairment of right-of-use assets

–

432

(Gain) loss on disposal of property and equipment

(9)

53

Placed units reserve

234

418

Interest paid in-kind

4,918

4,553

Non-cash interest expense

4,931

620

Amortization of discount on debt

429

368

Deferred income taxes

29

34

Changes in operating assets and liabilities:

Accounts receivable

1,986

212

Inventories

(407)

7,646

Prepaid expenses and other assets

506

(2,794)

Accounts payable

(579)

(315)

Contract liabilities

23

72

Accrued expenses and other liabilities

2,045

(3,460)

Operating lease liabilities, current and long-term

(1,288)

(1,213)

Net cash used in operating activities

(9,827)

(17,388)

Cash flows from investing activities

Purchases of property and equipment

(2,662)

(1,408)

Net cash used in investing activities

(2,662)

(1,408)

Cash flows from financing activities

Proceeds from issuance of common stock and pre-funded warrants and
   accompanying warrants in private placement, net of issuance costs

–

20,943

Proceeds from loans, net of discount

5,820

–

Proceeds from exercise of warrants

–

3

Proceeds from exercise of stock options

1

–

Proceeds from issuance of common stock under Employee Stock Purchase Plan

12

77

Net cash provided by financing activities

5,833

21,023

Effect of exchange rate changes on cash, cash equivalents and restricted cash

(165)

35

Net (decrease) increase in cash, cash equivalents and restricted cash

(6,821)

2,262

Cash, cash equivalents and restricted cash

Beginning of period

10,834

16,847

End of period

$

4,013

$

19,109

Supplemental disclosures of cash flow information

Interest paid during the period

$

3,557

$

2,720

Property and equipment purchases in accounts payable and accrued expenses

$

732

$

175

Issuance of common stock warrants in conjunction with long term debt

$

16

$

71

Issuance of common stock for services

$

155

$

117

Non-GAAP Financial Measures

The following table contains a reconciliation of net loss to Adjusted EBITDA for the three months ended June 30, 2024 and 2023, respectively.

Three Months Ended June 30,

2024

2023

(Unaudited)

(in thousands)

Net loss

$

(14,271)

$

(14,788)

Interest expense, net

4,943

4,616

Provision for income taxes

18

25

Depreciation and amortization

1,224

1,197

EBITDA

$

(8,086)

$

(8,950)

Merger-related costs

3,723

–

Stock-based compensation

1,456

2,585

Foreign currency loss (gain)

43

(9)

Gain from deconsolidation

–

(5)

Gain on disposal of property and equipment

(1)

(2)

Adjusted EBITDA

$

(2,865)

$

(6,381)

The following table contains a reconciliation of operating expenses to Non-GAAP operating expenses and Non-GAAP cash operating expenses for the three months ended June 30, 2024 and June 30, 2023, respectively.

Three Months Ended June 30,

2024

2023

(Unaudited)

(in thousands)

GAAP operating expenses

$

17,550

$

17,016

Merger-related costs

(3,723)

–

Gain on disposal of property and equipment

1

2

Non-GAAP operating expenses

13,828

17,018

Stock-based compensation

(1,423)

(2,534)

Depreciation and amortization

(262)

(293)

Gain from deconsolidation

–

5

Non-GAAP cash operating expenses

$

12,143

$

14,196

 

Supplemental Operating Metrics

June 30,

2024

2023

Change

Amount

Amount

Amount

%

HVT 2.0 and precision flow units installed base

United States

24,992

24,563

429

1.7

%

International

12,975

12,729

246

1.9

%

Total

37,967

37,292

675

1.8

%

Three Months Ended June 30,

2024

2023

Change

Amount

Amount

Amount

%

HVT 2.0 and precision flow units sold and leased

United States

193

293

(100)

(34.1)

%

International

99

146

(47)

(32.2)

%

Total

292

439

(147)

(33.5)

%

Disposable patient circuits sold

United States

82,290

69,323

12,967

18.7

%

International

29,634

35,744

(6,110)

(17.1)

%

Total

111,924

105,067

6,857

6.5

%

 

Investor Relations Contacts:

John Landry, SVP & CFO, ir@vtherm.com, +1 (603) 658-0011

View original content to download multimedia:https://www.prnewswire.com/news-releases/vapotherm-reports-second-quarter-2024-financial-results-302220359.html

SOURCE Vapotherm, Inc.

Continue Reading

Technology

Tencent Cloud Positioned in the 2026 Gartner® Magic Quadrant™ for Cloud Operational Database Management Systems

Published

on

By

SHENZHEN, China, Nov. 19, 2026 /PRNewswire/ — Recently, Gartner released its 2026 Magic Quadrant for Cloud Operational Database Management Systems. Tencent Cloud has been positioned in the Magic Quadrant.

The report assesses each vendor’s product capabilities, market practices, and future development roadmaps across two dimensions: Ability to Execute and Completeness of Vision. It focuses on how databases support mission-critical businesses and expand into areas such as operational analytics, vector search, and AI-ready data management.

According to the report, the global database management system market reached USD 140.2 billion in 2025, with cloud deployments (dbPaaS) accounting for 67% of total market spending. As AI applications expand, the business workloads handled by databases are also changing. Gartner notes that cloud operational databases are increasingly becoming highly reliable, structured memory stores for autonomous AI agents and intelligent applications.

From core banking systems to high-concurrency Internet businesses, Tencent Cloud continues to drive large-scale deployment of its self-developed databases in enterprise mission-critical operations. It combines the high reliability field-proven in financial scenarios with cloud-native technologies to improve elastic scalability and resource efficiency while ensuring business continuity.

In the financial sector, Tencent Cloud TDSQL has served the core systems of more than 100 financial institutions, spanning banking, securities, and insurance. In the banking industry, TDSQL has achieved full coverage across the core databases of China’s four largest state-owned banks, and eight of the country’s top ten banks have adopted TDSQL.

To address different business workloads, Tencent Cloud offers TDSQL as a distributed SQL database service and TDSQL-C to support cloud-native distributed applications.

In terms of cost and Ops, TDSQL-C’s serverless capabilities support automatic suspension and second-level wake-up, reducing computing resource consumption during idle periods. TencentDB for DBbrain provides real-time diagnostics, anomaly detection, and SQL throttling to help enterprises handle burst traffic and lower Ops overhead. Combined with billing options such as reserved resource pools and tiered usage discounts, Tencent Cloud provides more flexible cost plans for enterprise database migration and long-term operations.

To meet emerging AI application needs, Tencent Cloud has formed a database AI capability matrix covering elastic operations, multimodal data processing, business semantics, and memory, supporting the large-scale deployment of agents. Over the past year, agents created an average of more than 20,000 TDSQL-C instances per day, with active instances exceeding 1 million. The open-source project TencentDB Agent Memory has accumulated more than 30,000 GitHub stars, becoming a widely favored tool for building agent context capabilities among developers worldwide.

Gartner, Magic Quadrant for Cloud Operational Database Management Systems, By Masud Miraz, Aaron Rosenbaum, Ramke Ramakrishnan, Xingyu Gu, Michael Gonzales, Prasad Pore, Robin Schumacher, 12 November 2026. Gartner and Magic Quadrant are trademarks of Gartner, Inc. and/or its affiliates. Gartner does not endorse any company, vendor, product or service depicted in its publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner publications consist of the opinions of Gartner’s business and technology insights organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this publication, including any warranties of merchantability or fitness for a particular purpose.

View original content:https://www.prnewswire.com/apac/news-releases/tencent-cloud-positioned-in-the-2026-gartner-magic-quadrant-for-cloud-operational-database-management-systems-302945103.html

SOURCE Tencent Cloud

Continue Reading

Technology

OCBC Joins Global Testbed with GFTN, UWA’s QUISA and ST Engineering Exploring Quantum Computing for Real-World Banking Applications

Published

on

By

As quantum computing promises breakthroughs, OCBC joins GFTN’s Q-FINEX testbed, with the Quantum Information, Simulation and Algorithms (QUISA) centre at the University of Western Australia (UWA) as research partner and ST Engineering as implementation partner, to put the technology to the test in practical banking settings.

SINGAPORE, Nov. 19, 2026 /PRNewswire/ — Quantum computing has attracted growing interest from banks for its potential to tackle complex financial calculations beyond the practical reach of conventional systems. But it also poses a longer-term threat to widely used encryption, prompting financial institutions to invest in cybersecurity preparedness before the technology becomes commercially viable.

OCBC is joining a Singapore-led quantum computing initiative to test the technology’s potential applications in banking, as financial institutions prepare for a technology that could transform risk management and cybersecurity resilience.

The bank will develop and test a concrete use case through Q-FINEX (Quantum Finance Industry Experimentation), a testbed led by the Global Finance & Technology Network (GFTN), with ST Engineering as global implementation partner and researchers from the University of Western Australia (UWA).

Launched at the Black Swan Summit Australia in Perth in March 2026, Q-FINEX has identified nine potential applications spanning pricing and trading, risk and capital, and resilience and financial crime.

The collaboration will be showcased at the Singapore FinTech Festival (SFF) 2026, opening today, where OCBC and ST Engineering will participate in the Quantum Finance Experience Zone at the GFTN Lounge.

From Lab to Bank

Q-FINEX brings together financial institutions, technology companies, and academic researchers to test quantum technologies on real financial challenges. GFTN will coordinate the collaboration and scope the experiments.

ST Engineering will deploy Quantizant, its new AI-ready post-quantum cryptography readiness platform, to assess OCBC’s quantum readiness and develop a prioritised roadmap for post-quantum algorithm transition.

OCBC will also submit two use cases, one in credit and counterparty risk and one in optimisation, to UWA’s QUISA group. The UWA researchers will turn these use cases into new quantum and hybrid algorithms and compare them with conventional methods. ST Engineering can then implement the most promising ones. The aim is to find where quantum computing offers a measurable advantage in banking, while strengthening OCBC’s readiness for the quantum era.

Building on OCBC’s Quantum Roadmap

OCBC’s participation builds on a quantum roadmap first established in 2021 as part of the bank’s multi-year strategy to build capabilities for the next generation of emerging technologies. As one of the first banks to begin formal training in quantum technology for employees, the Singapore bank has trained more than 100 employees to an intermediate level of proficiency in quantum technology.

OCBC has worked closely with partners across the ecosystem, from regulators and telecommunications providers to universities, on quantum-safe communications, post-quantum security and quantum applications research. It has established research partnerships with the National University of Singapore, Nanyang Technological University and Singapore Management University to explore applications in derivatives pricing, portfolio optimisation and cybersecurity. Its participation in Q-FINEX builds on these investments, extending its quantum research into practical banking experimentation.

Sopnendu Mohanty, Group Chief Executive Officer, Global Finance & Technology Network (GFTN), said:

“Quantum computing could fundamentally change the economics and security of global finance. The question for banks is no longer whether to prepare, but how quickly they can build the capabilities to do so. We cannot afford to wait for the technology to mature before understanding its implications.

“With Q-FINEX, we are moving beyond speculation to evidence — bringing banks, engineers and researchers together to test real financial problems and establish where quantum computing can deliver value. OCBC’s participation is an important step towards building a financial system that is not only quantum-ready, but also capable of harnessing the next generation of computing innovation.”

Praveen Raina, Group Chief Information Officer, OCBC, said:

“Quantum computing will matter to banking on two fronts. It could help us solve problems in risk and optimisation that today’s systems can only approximate, and in time it will challenge the encryption that protects our customers’ data and transactions. We intend to be ready on both. Q-FINEX lets us put real banking problems in front of leading researchers and engineers, and find out where quantum actually outperforms the methods we use today. At the same time, we are charting our move to post-quantum cryptography while there is still time to do it in an orderly way. That is how we approach emerging technology at OCBC: start early, test rigorously, and scale only what proves its value.”

Tan Bin Ru, President, Enterprise (Digital), ST Engineering, said:

“The convergence of quantum computing and AI will create new opportunities for financial institutions, but also new risks. As we explore what these technologies can unlock, security and resilience must remain at the core. Through our collaboration with OCBC and GFTN, and with Quantizant, our new post-quantum cryptography readiness platform, ST Engineering is helping to translate deep technology into practical solutions for the financial sector, strengthening security today while preparing for a quantum-ready future.”

Media Contacts

Preeti Dawra
Chief Communications Officer
Global Finance & Technology Network
Preeti.Dawra@gftn.com 

Chelsea Lim
Group Brand and Communications
OCBC
Chelsealim1@ocbc.com 

Desiree Wong
VP, Group Corporate Communications
ST Engineering
desiree.wongmy@stengg.com 

About the Global Finance & Technology Network (GFTN)

Established by the Monetary Authority of Singapore (MAS) in 2024, the Global Finance & Technology Network (GFTN) is a not-for-profit organisation that connects global policy, tech and finance to build resilient, efficient and inclusive financial systems. GFTN Services convenes global forums in five continents with its network of over 140 countries, provides advisory and capacity-building services to central banks and governments in Asia, Africa and Europe, and supports investment in fintech innovation. Its flagship platforms include the Singapore FinTech Festival and Black Swan Summit. GFTN Capital is being established as a venture capital firm focused on investing in growth-stage fintech companies that combine commercial potential with positive social impact. For more information, visit (http://www.gftn.co).

About OCBC

OCBC is the longest established Singapore bank, formed in 1932 from the merger of three local banks, the oldest of which was founded in 1912. It is one of the world’s most highly-rated banks, with Aa1 by Moody’s and AA- by both Fitch and S&P. Recognised for its financial strength and stability, OCBC was ranked first in the inaugural World’s Top Performing Banks list by Forbes and Statista in 2026. In the same year, it was also named the strongest bank in Singapore and Asia Pacific, and the third strongest globally, by The Asian Banker.

OCBC is the second largest financial services group in Southeast Asia by assets. The Group offers a broad array of commercial banking, specialist financial and wealth management services, ranging from consumer, corporate, investment, private and transaction banking to treasury, insurance, asset management and stockbroking services.

OCBC’s private banking services are provided by its wholly-owned subsidiary Bank of Singapore, which operates on a unique open-architecture product platform to source for the best-in-class products to meet its customers’ goals. Its insurance subsidiary, Great Eastern Holdings, is the oldest and most established life insurance group in Singapore and Malaysia. Its asset management subsidiary, Lion Global Investors, is one of the leading asset management companies in Southeast Asia. Its brokerage subsidiary, OCBC Securities, is one of the leading securities firms in Singapore.

The Group’s key markets are Singapore, Malaysia, Indonesia and Greater China. It has close to 380 branches and representative offices in 19 countries and regions.

For more information, please visit www.ocbc.com.

About ST Engineering

ST Engineering is a global technology, defence and engineering group with a diverse portfolio of businesses across the aerospace, smart city, defence and public security segments. The Group harnesses technology and innovation to solve real-world problems, enabling a more secure and sustainable world. Headquartered in Singapore, it has operations spanning Asia, Europe, the Middle East and the U.S., serving customers in more than 100 countries. ST Engineering reported revenue of over S$12b in 2025 and ranks among the largest companies listed on the Singapore Exchange. It is a component stock of MSCI Singapore, FTSE Straits Times Index and Dow Jones Best-in-Class Asia Pacific Index. Follow ST Engineering on LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/ocbc-joins-global-testbed-with-gftn-uwas-quisa-and-st-engineering-exploring-quantum-computing-for-real-world-banking-applications-302945114.html

SOURCE Global Finance & Technology Network (GFTN)

Continue Reading

Technology

LiberNovo Launches Black Friday Sale With Maxis Offers, Holiday Gifts and Rewards

Published

on

By

HONG KONG, Nov. 19, 2026 /PRNewswire/ — LiberNovo has launched its Black Friday Sale in the United States and Canada, bringing its strongest public promotional pricing of the year to selected ergonomic chair bundles. Running through November 30, the event combines special prices across the Maxis and Omni ranges with tiered gifts, savings on larger orders, a Black Friday prize wheel and triple points for eligible VIP members.

The Maxis Series leads the sale, offering taller and larger users three ways to upgrade the seat behind their workday. For holiday shoppers planning a home-office refresh or choosing a gift for someone who spends long hours at a desk, the range provides a choice of manual adjustment, electric support and active ventilation.

Maxis Manual offers the essentials of manual adjustment. Maxis Electric adds electric lumbar support and OmniStretch, while Maxis Airflow builds on those features with active seat ventilation. Customers can choose according to their daily routines, preferred features and budget.

In the United States, Maxis Basic Bundles are priced at US$849 for Maxis Manual, US$1,099 for Maxis Electric and US$1,299 for Maxis Airflow. Canadian prices are CA$1,239, CA$1,579 and CA$1,859, respectively.

Omni Pro provides another feature-rich option, combining electric lumbar support, stretching and seat ventilation, with Basic Bundles priced at US$919 in the United States and CA$1,439 in Canada. Omni SE Basic Bundles offer a more accessible starting point at US$609 in the United States and CA$889 in Canada. Participating models and promotional prices vary by market.

Every LiberNovo chair is backed by a 6-year warranty on the frame and components and 2 years on electronics. Eligible purchases are covered by LiberNovo’s 30-Day Price Protection during the Black Friday Sale. Full terms are available on the regional website.

Three Gift Tiers and Savings on Larger Orders

LiberNovo’s site-wide Spend & Gift promotion adds a gift package to qualifying purchases. In the United States, the first tier is the Eco-Comfort Upgrade Kit, including a mouse pad, at an order threshold of US$800. In Canada, the first tier remains the Smart Entry Bundle at an order threshold of CA$1,200. Higher tiers include the Eco-Comfort Upgrade Kit and Ergo-to-Go Travel Suite, with gift contents, availability and eligibility following the applicable regional terms.

Spend & Save provides additional savings for larger purchases. Qualifying US orders receive US$60 off every US$2,000, US$100 off every US$3,000 or US$180 off every US$4,000. Canadian thresholds and savings are set in Canadian dollars on the regional website. Whether these savings can be combined with other offers depends on the local terms.

Black Friday Rewards and Flexible Payments

Qualifying orders also receive one complimentary Black Friday prize-wheel spin, with entry thresholds of US$800 in the United States and CA$1,200 in Canada. Potential rewards include a free order, Omni SE and Omni Pro chairs, footrests, eye masks, blankets and footrest cushions. Coupon rewards include US$5 or CA$5 vouchers, as applicable. Entry conditions, prize availability, minimum coupon rewards and free-order rules follow each market’s published promotion terms.

Eligible VIP members earn triple points on qualifying purchases during the sale. Membership eligibility, points issuance and redemption restrictions are governed by the regional loyalty-program rules.

Refer a Friend continues to offer savings for both referrers and their friends. Eligible customers can also divide their purchase into four interest-free payments, subject to the financing options and eligibility requirements displayed at checkout.

Comfort for Home Offices and Teams

A chair upgrade can form part of a home-office refresh, support a family member’s desk setup or provide a practical holiday gift chosen around how someone works and relaxes. The range gives shoppers room to match that choice to the person, from essential ergonomic support to electric adjustment and ventilation.

For businesses planning year-end purchases, LiberNovo’s Business & Bulk Orders program supports orders of five or more chairs. Options span the Omni and Maxis ranges, with chair-only and chair-and-footrest combinations. Regional Spend & Save offers can help teams plan workstation upgrades within their available budget, subject to the applicable combination rules.

The Black Friday Sale ends November 30 at 11:59 p.m. PST in the United States and 11:59 p.m. EST in Canada. Visit LiberNovo US or LiberNovo Canada for participating products, current prices, availability, membership eligibility and complete promotional terms.

About LiberNovo

LiberNovo is an ergonomic seating brand built on Dynamic Ergonomics, designing chairs that support natural movement and sustained comfort. Its Omni and Maxis ranges offer adaptable support for different body types and daily routines, from home offices and gaming setups to professional workplaces. Learn more at libernovo.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/libernovo-launches-black-friday-sale-with-maxis-offers-holiday-gifts-and-rewards-302943502.html

SOURCE LIBERNOVO HK CO., LIMITED

Continue Reading

Trending